- The Federal Circuit invalidated on obviousness grounds the patent for the once-a-week version of Merck's Fosamax, which dominates the market for osteoporosis drugs. Under the ruling, generic competition could begin as soon as early 2008, instead of 2018. Article available here.
- And for the tennis fans, Auto-Ref Inc., owner of technology designed to bring more accuracy to the game of tennis, announced today from the Australian Open that it has received the U.S. patent 6,816,185 for "System and Method for Judging Boundary Lines."
No comments:
Post a Comment